NCT01946880: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT01946880 |
|---|---|
| Title | An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE) |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Nov. 20, 2013 |
| Completion date | July 3, 2019 |
| Required reporting date | July 2, 2020, midnight |
| Actual reporting date | July 3, 2020 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |